Internal Reference Number: FOI_7074
Date Request Received: 16/03/2023 00:00:00
Date Request Replied To: 11/04/2023 00:00:00
This response was sent via: By Email
Request Summary: Treatment of Colorectal Cancer
Request Category: Companies
| Question Number 1: How many colorectal cancer [CRC] patients have been treated in the past 3 months with the following agents: • Aflibercept • Bevacizumab • Capecitabine • CAPIRI • CAPOX (XELOX) • Cetuximab in combination with FOLFIRI • Cetuximab in combination with FOLFOX • Cetuximab not in combination with FOLFIRI or FOLFOX • Irinotecan only • FOLFIRI • FOLFOX • Fluorouracil (5FU) only • Oxaliplatin only • Panitumumab in combination with FOLFIRI • Panitumumab in combination with FOLFOX • Panitumumab not in combination with FOLFIRI or FOLFOX • Pembrolizumab • Nivolumab • Raltitrexed • Ramucirumab • Regorafenib • Sorafenib • Other active systemic anti-cancer therapy • Palliative care only | |
| Answer To Question 1: How many colorectal cancer [CRC] patients have been treated in the past 3 months with the following agents: • Aflibercept 0 • Bevacizumab 0 • Capecitabine <5 • CAPIRI 0 • CAPOX (XELOX) 22 • Cetuximab in combination with FOLFIRI 0 • Cetuximab in combination with FOLFOX 0 • Cetuximab not in combination with FOLFIRI or FOLFOX 0 • Irinotecan only 0 • FOLFIRI <5 • FOLFOX 6 • Fluorouracil (5FU) only 0 • Oxaliplatin only 0 • Panitumumab in combination with FOLFIRI <5 • Panitumumab in combination with FOLFOX <5 • Panitumumab not in combination with FOLFIRI or FOLFOX 0 • Pembrolizumab <5 • Nivolumab 0 • Raltitrexed 0 • Ramucirumab 0 • Regorafenib 0 • Sorafenib 0 • Other active systemic anti-cancer therapy <5 • Palliative care only unable to answer | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of ¿´Æ¬Èí¼þ Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
